Actively Recruiting

Phase Not Applicable
Age: 18Years - 30Years
All Genders
Healthy Volunteers
NCT07178353

Human Skeletal Muscle Response to 5 Days of Bedrest in Young Adults

Led by Queen's University · Updated on 2025-09-22

12

Participants Needed

1

Research Sites

91 weeks

Total Duration

On this page

Sponsors

Q

Queen's University

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this intervention trial is to characterize skeletal muscle atrophy in healthy, young adults during short term bedrest. The main questions it aims to answer are: How much do skeletal muscle volume, strength, and fatigue resistance decline during bedrest? How much does whole-body insulin sensitivity change during bedrest? How do mitochondrial function and protein synthesis change during bedrest? Participants will undergo the following tests before and after a free-living control period and before and after a 5 day period of strict horizontal bedrest: * Magnetic resonance imaging of the thigh muscles * Strength testing of the thigh muscles * Insulin sensitivity testing in response to a mixed meal * Exogenous glucose oxidation in response to a mixed meal * Muscle biopsies from the thigh muscles * Blood samples

CONDITIONS

Official Title

Human Skeletal Muscle Response to 5 Days of Bedrest in Young Adults

Who Can Participate

Age: 18Years - 30Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and females 18-30 years old
  • BMI between 18.5 and 28 kg/m2
  • Weight stable within plus or minus 2 kg for the past 6 months
  • Generally healthy as assessed by medical and physical activity questionnaires
  • Recreationally active
Not Eligible

You will not qualify if you...

  • BMI below 18.5 or above 28 kg/m2
  • Use of insulin to control blood glucose levels
  • History of cardiovascular, respiratory, metabolic, neuromuscular, or bone-wasting diseases
  • Use of medications that affect muscle protein turnover (e.g., androgen or anabolic hormone therapy, chemotherapy)
  • History of thrombosis, platelet or coagulation disorders, antiplatelet therapy, or anticoagulant medication use
  • Presence of unremoved or partially removed metals under the skin
  • History of head or eye injury involving metal fragments
  • Having implanted electrical devices like pacemakers or neurostimulators
  • Having implanted metal objects from surgery such as artificial joints or aneurysm clips
  • Being pregnant or possibly pregnant
  • Wearing metal braces on teeth

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Queen's Univeristy

Kingston, Ontario, Canada, K7L 3N6

Actively Recruiting

Loading map...

Research Team

C

Chris McGlory, PhD.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here